AP
AMEX · APUS
Apimeds Pharmaceuticals US, Inc
Healthcare · Drug Manufacturers - Specialty & Generic
$1.64
Down-$0.02 (-1.22%)
Updated Sep 16, 2026, 3:54 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 17.1M
- P/E ratio
- -3.32
- Dividend yield
- 0.00%
- 52-week range
- $0.62 – $21.00
- Volume
- 66.3K
- Avg. volume
- 163.68K
Price performance
APUS price history
1M range · 20 trading sessions · Daily adjusted prices
APUS closed at $1.64 after 20 trading sessions, down 59.00% for the selected period.
- Last close
- $1.64
- Period change
- -59.00%
- Period low
- $1.64
- Period high
- $4.97
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.11 | $2.1101 | $1.60 | $1.64 | 66.3K |
| Sep 14, 2026 | $2.39 | $2.39 | $2.025 | $2.09 | 29.82K |
| Sep 11, 2026 | $2.16 | $2.26 | $2.09 | $2.105 | 20.69K |
| Sep 10, 2026 | $2.26 | $2.47 | $2.12 | $2.17 | 41.16K |
| Sep 9, 2026 | $2.30 | $2.35 | $2.17 | $2.29 | 29.57K |
| Sep 8, 2026 | $2.40 | $2.405 | $2.25 | $2.30 | 17.42K |
| Sep 4, 2026 | $2.49 | $2.60 | $2.42 | $2.42 | 24.39K |
| Sep 3, 2026 | $2.66 | $2.71 | $2.40 | $2.51 | 50.66K |
| Sep 2, 2026 | $3.17 | $3.38 | $2.5101 | $2.63 | 85.51K |
| Sep 1, 2026 | $3.87 | $3.87 | $3.41 | $3.54 | 29.31K |
| Aug 31, 2026 | $4.09 | $4.09 | $3.73 | $3.88 | 8.25K |
| Aug 28, 2026 | $4.10 | $4.10 | $3.861 | $3.87 | 9.07K |
| Aug 27, 2026 | $4.63 | $4.81 | $3.7366 | $3.95 | 172.41K |
| Aug 26, 2026 | $4.74 | $4.99 | $4.358 | $4.60 | 230.14K |
| Aug 25, 2026 | $4.78 | $5.35 | $4.65 | $4.97 | 49.12K |
| Aug 24, 2026 | $4.34 | $4.75 | $4.34 | $4.75 | 15.93K |
| Aug 21, 2026 | $4.30 | $5.43 | $4.175 | $4.84 | 559.64K |
| Aug 20, 2026 | $4.23 | $4.50 | $4.0911 | $4.39 | 17.21K |
| Aug 19, 2026 | $3.88 | $4.55 | $3.69 | $4.39 | 23.44K |
| Aug 18, 2026 | $3.99 | $4.30 | $3.85 | $4.00 | 38.21K |
Latest APUS news
The latest Smart Investors Daily articles mentioning APUS.
Stock researchResearch & News · News
Loading stock research…
